New vaccines against mucosal pathogens: rotavirus and respiratory syncytial virus.
Coffin
S E
SE
Children's Hospital of Philadelphia, Pennsylvania, USA.
Offit
P A
PA
D000328:Adult; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D012087:Reoviridae / Q000276:immunology; D018357:Respiratory Syncytial Virus Infections / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control; D018113:Respiratory Syncytial Virus, Human / Q000737:chemistry / Q000276:immunology*; D012401:Rotavirus / Q000737:chemistry / Q000276:immunology*; D012400:Rotavirus Infections / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control; D014481:United States / Q000453:epidemiology; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology; D019444:Vaccines, DNA / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology; D015164:Vaccines, Inactivated / Q000008:administration & dosage / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology*
D014613:Vaccines, Attenuated; D019444:Vaccines, DNA; D015164:Vaccines, Inactivated; D014765:Viral Vaccines